Total marketcap
Total volume
BTC 49.75%     ETH 16.78%

Novo Nordisk A/S NONOF Stock

123.5 USD {{ price }} 3.729214% {{change_pct}}%
Other OTC
Market Cap
561.58B USD
LOW - HIGH [24H]
122.3 - 125.8 USD
33.14K USD
{{ volume }}
P/E Ratio
Earnings per share
2.7 USD

Novo Nordisk A/S Price Chart

Novo Nordisk A/S NONOF Financial and Trading Overview

Novo Nordisk A/S stock price 123.5 USD
Previous Close 98.6 USD
Open 96.55 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 95.73 - 98.47 USD
52 Week Range 64.08 - 108.51 USD
Volume 24.85K USD
Avg. Volume 27.7K USD
Market Cap 432.27B USD
Beta (5Y Monthly) 0.194
PE Ratio (TTM) 39.10569
Forward Dividend & Yield 1.03 (1.06%)
Ex-Dividend Date August 18, 2023
1y Target Est N/A

NONOF Valuation Measures

Enterprise Value 409.62B USD
Trailing P/E 39.10569
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.01532
Price/Book (mrq) 4.6314573
Enterprise Value/Revenue 1.91
Enterprise Value/EBITDA 4.092

Trading Information

Novo Nordisk A/S Stock Price History

Beta (5Y Monthly) 0.194
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 108.51 USD
52 Week Low 64.08 USD
50-Day Moving Average 98.65 USD
200-Day Moving Average 87.16 USD

NONOF Share Statistics

Avg. Volume (3 month) 27.7K USD
Avg. Daily Volume (10-Days) 51.12K USD
Shares Outstanding 3.38B
Float 3.31B
Short Ratio N/A
% Held by Insiders 5.97%
% Held by Institutions 38.40%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 7.075
Trailing Annual Dividend Yield 7.17%
5 Year Average Dividend Yield 156.00%
Payout Ratio 0.42310002
Last Split Factor 5:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) September 30, 2023
Next Fiscal Year End December 31, 2023


Profit Margin 35.11%
Operating Margin (ttm) 45.82%
Gross Margin 84.14%
EBITDA Margin 46.67%

Management Effectiveness

Return on Assets (ttm) 21.57%
Return on Equity (ttm) 88.77%

Income Statement

Revenue (ttm) 214.49B USD
Revenue Per Share (ttm) 47.73 USD
Quarterly Revenue Growth (yoy) 28.89%
Gross Profit (ttm) 148.51B USD
Net Income Avi to Common (ttm) 75.31B USD
Diluted EPS (ttm) 2.46
Quarterly Earnings Growth (yoy) 56.00%

Balance Sheet

Total Cash (mrq) 47.59B USD
Total Cash Per Share (mrq) 10.63 USD
Total Debt (mrq) 26.54B USD
Total Debt/Equity (mrq) 28.54 USD
Current Ratio (mrq) 0.824
Book Value Per Share (mrq) 20.771

Cash Flow Statement

Operating Cash Flow (ttm) 106.46B USD
Levered Free Cash Flow (ttm) 63.8B USD

Profile of Novo Nordisk A/S

Country United States
State N/A
City Bagsvaerd
Address Novo Alle 1
ZIP 2880
Phone 45 44 44 88 88
Website https://www.novonordisk.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 61412

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Q&A For Novo Nordisk A/S Stock

What is a current NONOF stock price?

Novo Nordisk A/S NONOF stock price today per share is 123.5 USD.

How to purchase Novo Nordisk A/S stock?

You can buy NONOF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Novo Nordisk A/S?

The stock symbol or ticker of Novo Nordisk A/S is NONOF.

Which industry does the Novo Nordisk A/S company belong to?

The Novo Nordisk A/S industry is Biotechnology.

How many shares does Novo Nordisk A/S have in circulation?

The max supply of Novo Nordisk A/S shares is 4.55B.

What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?

Novo Nordisk A/S PE Ratio is 45.74074000 now.

What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?

Novo Nordisk A/S EPS is 2.7 USD over the trailing 12 months.

Which sector does the Novo Nordisk A/S company belong to?

The Novo Nordisk A/S sector is Healthcare.